Recommendations for extracellular vesicle miRNA biomarker research in the endometrial cancer context

Endometrial cancer (EC) is the most common gynaecological malignancy in the developed world, and concerningly incidence is rising, particularly in younger people. Therefore, there is increased interest in novel diagnostic and prognostic biomarkers. Extracellular vesicles (EVs) are membrane-bound par...

Full description

Bibliographic Details
Main Authors: Emily Paterson, Cherie Blenkiron, Kirsty Danielson, Claire Henry
Format: Article
Language:English
Published: Elsevier 2022-09-01
Series:Translational Oncology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1936523322001371
_version_ 1818108547915841536
author Emily Paterson
Cherie Blenkiron
Kirsty Danielson
Claire Henry
author_facet Emily Paterson
Cherie Blenkiron
Kirsty Danielson
Claire Henry
author_sort Emily Paterson
collection DOAJ
description Endometrial cancer (EC) is the most common gynaecological malignancy in the developed world, and concerningly incidence is rising, particularly in younger people. Therefore, there is increased interest in novel diagnostic and prognostic biomarkers. Extracellular vesicles (EVs) are membrane-bound particles present in bodily fluids that have the potential to facilitate non-invasive, early diagnosis of EC and could aid with monitoring of recurrence and treatment response. EV cargo provides molecular insight into the tumor, with the lipid bilayer providing stability for RNA species usually prone to degradation. miRNAs have recently become a focus for EV biomarker research due to their ability to regulate cancer related pathways and influence cancer development and progression. This review evaluates the current literature on EV miRNA biomarkers with a focus on EC, and discusses the challenges facing this research. This review finally highlights areas of focus for EV miRNA biomarker research going forward, such as standardization of normalization approaches, sample storage and processing, extensive reporting of methodologies and moving away from single miRNA biomarkers.
first_indexed 2024-12-11T02:17:06Z
format Article
id doaj.art-39a5ac65d2b3480aaa2014def21ea304
institution Directory Open Access Journal
issn 1936-5233
language English
last_indexed 2024-12-11T02:17:06Z
publishDate 2022-09-01
publisher Elsevier
record_format Article
series Translational Oncology
spelling doaj.art-39a5ac65d2b3480aaa2014def21ea3042022-12-22T01:24:10ZengElsevierTranslational Oncology1936-52332022-09-0123101478Recommendations for extracellular vesicle miRNA biomarker research in the endometrial cancer contextEmily Paterson0Cherie Blenkiron1Kirsty Danielson2Claire Henry3Department of Obstetrics, Gynaecology and Women's Health, University of Otago, Wellington, New ZealandFaculty of Medical and Health Sciences, University of Auckland, Auckland, New ZealandDepartment of Surgery and Anaesthesia, University of Otago, Wellington, New ZealandDepartment of Obstetrics, Gynaecology and Women's Health, University of Otago, Wellington, New Zealand; Corresponding author.Endometrial cancer (EC) is the most common gynaecological malignancy in the developed world, and concerningly incidence is rising, particularly in younger people. Therefore, there is increased interest in novel diagnostic and prognostic biomarkers. Extracellular vesicles (EVs) are membrane-bound particles present in bodily fluids that have the potential to facilitate non-invasive, early diagnosis of EC and could aid with monitoring of recurrence and treatment response. EV cargo provides molecular insight into the tumor, with the lipid bilayer providing stability for RNA species usually prone to degradation. miRNAs have recently become a focus for EV biomarker research due to their ability to regulate cancer related pathways and influence cancer development and progression. This review evaluates the current literature on EV miRNA biomarkers with a focus on EC, and discusses the challenges facing this research. This review finally highlights areas of focus for EV miRNA biomarker research going forward, such as standardization of normalization approaches, sample storage and processing, extensive reporting of methodologies and moving away from single miRNA biomarkers.http://www.sciencedirect.com/science/article/pii/S1936523322001371Extracellular vesiclesmiRNAsBiomarkersEndometrial cancer
spellingShingle Emily Paterson
Cherie Blenkiron
Kirsty Danielson
Claire Henry
Recommendations for extracellular vesicle miRNA biomarker research in the endometrial cancer context
Translational Oncology
Extracellular vesicles
miRNAs
Biomarkers
Endometrial cancer
title Recommendations for extracellular vesicle miRNA biomarker research in the endometrial cancer context
title_full Recommendations for extracellular vesicle miRNA biomarker research in the endometrial cancer context
title_fullStr Recommendations for extracellular vesicle miRNA biomarker research in the endometrial cancer context
title_full_unstemmed Recommendations for extracellular vesicle miRNA biomarker research in the endometrial cancer context
title_short Recommendations for extracellular vesicle miRNA biomarker research in the endometrial cancer context
title_sort recommendations for extracellular vesicle mirna biomarker research in the endometrial cancer context
topic Extracellular vesicles
miRNAs
Biomarkers
Endometrial cancer
url http://www.sciencedirect.com/science/article/pii/S1936523322001371
work_keys_str_mv AT emilypaterson recommendationsforextracellularvesiclemirnabiomarkerresearchintheendometrialcancercontext
AT cherieblenkiron recommendationsforextracellularvesiclemirnabiomarkerresearchintheendometrialcancercontext
AT kirstydanielson recommendationsforextracellularvesiclemirnabiomarkerresearchintheendometrialcancercontext
AT clairehenry recommendationsforextracellularvesiclemirnabiomarkerresearchintheendometrialcancercontext